opportunistic infections

Summary

Summary: An infection caused by an organism which becomes pathogenic under certain conditions, e.g., during immunosuppression.

Research Grants

  1. MECHANISM-BASED DRUG SELECTION AND DESIGN: NUCLEOTIDE SA
    Buddy Ullman; Fiscal Year: 2003
  2. WI State Public Health Lab Capacity for SCID Screening
    CHARLES DENNIS BROKOPP; Fiscal Year: 2008
  3. Development of Vaccines Against Retrovirus Infection in
    RAOUL BENVENISTE; Fiscal Year: 2004
  4. Evaluation of HIV-related Complications
    Joseph A Kovacs; Fiscal Year: 2006
  5. Treatment for HIV-Associated Cytomegalovirus Retinitis
    Michael R Robinson; Fiscal Year: 2004
  6. Role Of Monocytes In AIDS And As Targets For Antiviral T
    Sharon M Wahl; Fiscal Year: 2006
  7. Mucosal Immune Barrier in Infection and Immunity
    Keith E Mostov; Fiscal Year: 2008
  8. Inhibition of HCV as an Opportunistic HIV Co-infection
    Ramachandra S Hosmane; Fiscal Year: 2008
  9. Imaging Infused CD19 Specific T Cells in the Tumor
    LAURENCE JN COOPER; Fiscal Year: 2008
  10. Imaging Infused CD19 Specific T Cells in the Tumor
    LAURENCE JN COOPER; Fiscal Year: 2007

Publications

  1. Fluconazole versus itraconazole for antifungal prophylaxis in neutropenic patients with haematological malignancies: a meta-analysis of randomised-controlled trials
    Konstantinos Z Vardakas
    Alfa Institute of Biomedical Sciences (AIBS, Athens, Greece
    Br J Haematol 131:22-8
  2. Fatal necrotizing stomatitis due to Trichoderma longibrachiatum in a neutropenic patient with malignant lymphoma: a case report
    Y Myoken
    Department of Oral Surgery, Hiroshima Red Cross and Atomic Bomb Survivors Hospital, Hiroshima, Japan
    Int J Oral Maxillofac Surg 31:688-91
  3. [Infections in immunosuppressed children]
    Karianne Wiger
    Barnemedisinsk avdeling, Ullevål universitetssykehus, 0407 Oslo
    Tidsskr Nor Laegeforen 125:1168-72
  4. A novel type of metastatically spreading subcutaneous aspergillosis without epidermal lesions following allogeneic stem cell transplantation
    O A Cornely
    Department I of Internal Medicine, Hematology, Oncology and Infectious Diseases, University of Cologne, Cologne, Germany
    Bone Marrow Transplant 28:899-901
  5. Fungal infections in nontransplant patients with hematologic malignancies
    Brahm H Segal
    Division of Infectious Diseases, SUNY at Buffalo, Roswell Park Cancer Institute, Elm and Carlton Streets, Buffalo, NY 14263, USA
    Infect Dis Clin North Am 16:935-64, vii
  6. Changing patterns and trends in systemic fungal infections
    Malcolm D Richardson
    Department of Bacteriology and Immunology, University of Helsinki, Helsinki, Finland
    J Antimicrob Chemother 56:i5-i11
  7. [Infections in stem cell transplantation]
    Montserrat Rovira
    Unidad de Trasplantament, Servicio Hematología, Hospital Clínic, Barcelona, España
    Enferm Infecc Microbiol Clin 25:477-86
  8. Prolonged survival after invasive aspergillosis: a single-institution review of 11 cases
    Jessica A Wright
    Department of Pediatrics, University of Washington School of Medicine, Seattle, Washington 98105 0371, USA
    J Pediatr Hematol Oncol 25:286-91
  9. [Successful treatment by voliconazole for pulmonary and adductor magnus muscle aspergillosis induced by immunosuppressive therapy for hypersensitivity pneumonia]
    Hidenori Ichiyasu
    Department of Respiratory Medicine, Faculty of Medical and Pharmaceutical Sciences, Kumamoto University
    Nihon Kokyuki Gakkai Zasshi 44:754-60
  10. Disseminated Ochroconis gallopavum infection in a chronic lymphocytic leukemia: a case report and review of the literature on hematological malignancies
    Noriyasu Fukushima
    Department of Internal Medicine, Faculty of Medicine, Saga University, Japan
    Intern Med 44:879-82

Scientific Experts

Detail Information

Webpages71 found, 30 most recent shown here

  1. infectious diseases
    mansfield.osu.edu/~sabedon/biol4070.htm
  2. statewide program for infection control and epidemiology/guidelines
    www.unc.edu/depts/spice/new.html
  3. bsci 424 pathogenic microbiology -- staphylococcus
    www.life.umd.edu/classroom/bsci424/PathogenDescriptions/Stap ...
  4. hiv vocabulary & study guide
    bio.classes.ucsc.edu/bio80as/Vocabulary/HIVocabStudy.html
  5. mycology online -- trichosporon
    www.mycology.adelaide.edu.au/Fungal_Descriptions/Yeasts/Tric ...
  6. dermatlas: online dermatology image library dermatology image,carcinoma, squamous cell, adenoid cystic,adenoid cystic carcinoma,carcinoma, squamous cell, adenoid cystic,carcinoma, squamous cell, adenoid cystic,carcinoma, squamous cell, adenoid cystic,carc
    dermatlas.med.jhmi.edu/derm/result.cfm?BodySite=75049588
  7. university of florida shands cancer center: campath® (alemtuzumab) effective in patients with mycosis fungoides/sezary syndrome who have failed previous therapy
    ufscc.ufl.edu/Professional/cancernews.aspx?section=cancernew ...
  8. dermatlas: online dermatology image library dermatology image,zygomycosis,fungal infection, deep,immunodeficiency, acquired,fungal infection, deep,immunodeficiency, acquired
    dermatlas.med.jhmi.edu/derm/result.cfm?Author=647724052
  9. mycology online -- trichosporon
    www.mycology.adelaide.edu.au/Fungal_Descriptions/Yeasts/Tric ...
  10. resources
    www.ritm.gov.ph/resource.htm
  11. bsci 424 pathogenic microbiology -- corynebacterium
    www.life.umd.edu/classroom/bsci424/PathogenDescriptions/Cory ...
  12. immunocompromised host: from the early events until the impact of acquired immunodeficiency syndrome
    memorias.ioc.fiocruz.br/95sup1/24c.html
  13. hiv/aids bureau - hiv care pocket guide 2006 - opportunistic infections
    www.hab.hrsa.gov/tools/HIVpocketguide/PktGOItables.htm
  14. anorexia and cachexia
    www.cgmh.org.tw/intr/intr5/c6700/OBGYN/f/web/Cachexia/index. ...
  15. transplant rejection treatment
    biomed.brown.edu/Courses/BI108/BI108_2004_Groups/Group04/Sid ...
  16. radiology, university of rochester medical center
    www.urmc.rochester.edu/smd/Rad/neurocases/Neurocase09.htm
  17. utmb toxicology faculty & research
    www.gsbs.utmb.edu/toxicology/faculty.htm
  18. severe combined immunodeficiency (scid) in arabian foals
    www.addl.purdue.edu/newsletters/2000/winter/scid.shtml
  19. case 2: discussion - a 40-year-old with fever and respiratory symptoms - opportunistic infections: treatment - hiv web study
    depts.washington.edu/hivaids/oit/case2/discussion.html
  20. memórias on line
    memorias.ioc.fiocruz.br/974/review974.html
  21. ahrq webm&m: case & commentary
    webmm.ahrq.gov/case.aspx?caseID=40
  22. nejm -- microsporidia infection in patients with the human immunodeficiency virus and unexplained cholangitis
    content.nejm.org/cgi/content/abstract/328/2/95
  23. faculty and research : cummings school of veterinary medicine at tufts university
    www.tufts.edu/vet/facpages/tzipori_s.html
  24. fungi and disease
    www.bmb.leeds.ac.uk/mbiology/ug/ugteach/dental/tutorials/fun ...
  25. medical protozoology syllabus
    www.tulane.edu/~wiser/protozoology/syllabus.html
  26. final diagnosis -- case 391
    path.upmc.edu/cases/case391/dx.html
  27. djo | digital journal of ophthalmology
    www.djo.harvard.edu/site.php?url=/physicians/oa/674&drop=0
  28. mycobacterium avium complex and atypical mycobacterial infections in the setting of hiv infection
    hivinsite.ucsf.edu/InSite?page=kb-00&doc=kb-05-01-05
  29. nosocomial infections
    www.mansfield.ohio-state.edu/~sabedon/biol2053.htm

Research Grants62

  1. MECHANISM-BASED DRUG SELECTION AND DESIGN: NUCLEOTIDE SA
    Buddy Ullman; Fiscal Year: 2003
    ..R01 application was submitted in response to PA AI-98-100, "National Cooperative Drug Discovery Groups-Opportunistic Infections" (NCDDG-OI) by a group of investigators from the Oregon Health Sciences University, the University of ..
  2. WI State Public Health Lab Capacity for SCID Screening
    CHARLES DENNIS BROKOPP; Fiscal Year: 2008
    ..Hence, most SCID infants are not recognized until diagnosed with life-threatening opportunistic infections, resulting in substantial morbidities and reduced overall survival of 50-70% Thus, the ability to detect ..
  3. Development of Vaccines Against Retrovirus Infection in
    RAOUL BENVENISTE; Fiscal Year: 2004
    ..of HIV infection and progression to AIDS in humans, including loss of CD4+ T cells and susceptibility to opportunistic infections. In this animal model, individuals can be inoculated at a specific time, by defined routes, and with ..
  4. Evaluation of HIV-related Complications
    Joseph A Kovacs; Fiscal Year: 2006
    ..and mortality associated with HIV infection, it has not eliminated HIV-related complications, such as opportunistic infections and malignancies...
  5. Treatment for HIV-Associated Cytomegalovirus Retinitis
    Michael R Robinson; Fiscal Year: 2004
    ..Death is most commonly from opportunistic infections such as pneumococcal pneumonia and tuberculosis...
  6. Role Of Monocytes In AIDS And As Targets For Antiviral T
    Sharon M Wahl; Fiscal Year: 2006
    ..Immunodeficiency, the consequence of HIV-1 infection, predisposes the host to opportunistic infections. In turn, opportunistic infections influence target cell susceptibility to HIV-1 infection and ..
  7. Mucosal Immune Barrier in Infection and Immunity
    Keith E Mostov; Fiscal Year: 2008
    ..These include HIV, sexually transmitted diseases, numerous opportunistic infections, TB, many emerging and re-emerging infections, and biological warfare/terrorist agents, such as anthrax, ..
  8. Inhibition of HCV as an Opportunistic HIV Co-infection
    Ramachandra S Hosmane; Fiscal Year: 2008
    ..Out of the HIV opportunistic infections, HCV in particular has lately taken the center stage, and is causing alarms in the AIDS research ..
  9. Imaging Infused CD19 Specific T Cells in the Tumor
    LAURENCE JN COOPER; Fiscal Year: 2008
    ..Adoptive transfer of antigen-specific T cells can augment the immune response to prevent and treat opportunistic infections and malignancies...
  10. Imaging Infused CD19 Specific T Cells in the Tumor
    LAURENCE JN COOPER; Fiscal Year: 2007
    ..Adoptive transfer of antigen-specific T cells can augment the immune response to prevent and treat opportunistic infections and malignancies...
  11. Inhibition of NADPH oxidase by Anaplasma phagocytophila
    Jason A Carlyon; Fiscal Year: 2007
    ..neutropenia, hypotension, shock, and may potentially be fatal due to myocarditis, pancarditis, or to opportunistic infections resulting from impaired host defense mechanisms...
  12. Vaccine-enhanced DLI to prevent cancer recurrence after stem cell transplantation
    John D Roback; Fiscal Year: 2006
    ..immunity following allogeneic hematopoietic stem cell transplantation (HSCT) predisposes patients to opportunistic infections and tumor recurrence...
  13. Inhibition of NADPH oxidase by Anaplasma phagocytophila
    Jason A Carlyon; Fiscal Year: 2007
    ..neutropenia, hypotension, shock, and may potentially be fatal due to myocarditis, pancarditis, or to opportunistic infections resulting from impaired host defense mechanisms...
  14. DRUGS AND DELIVERY SYSTEMS FOR OPPORTUNISTIC INFECTIONS
    Marvin J Miller; Fiscal Year: 2002
    ..The general goal of this proposed research is to develop new methods and agents for the treatment of opportunistic infections associated with AIDS and other diseases in which the immune system is compromised...
  15. HIV-1 Clade Diversity and Macrophage Mediated Neurotoxicity in HIV-1 Dementia
    JIALIN CHARLES ZHENG; Fiscal Year: 2008
    ..pathogenesis or simply an artifact of confounding variables such as data sampling, clinical diagnosis or opportunistic infections is unclear...
  16. Genome Integrity in Candida albicans
    Judith G Berman; Fiscal Year: 2008
    DESCRIPTION (provided by applicant): Opportunistic infections remain the most important complication of infection with the Human Immunodeficiency Virus (HIV) and the principal cause of death in patients with the Acquired Immune Deficiency ..
  17. Human Beta-Defensin-1 in HSV-1 Innate Immunity
    LISA KATHLEEN RYAN; Fiscal Year: 2008
    ..PDC in the circulation, along with depletion of CD4 T-lymphocytes is associated with the development of opportunistic infections, including viral infections...
  18. Structure, dynamics, and function of the viroporins Vpu from HIV and p7 from HCV
    Stanley J Opella; Fiscal Year: 2008
    ..CD4+ T and other cells of the immune system; the resulting decline of immune functions means that opportunistic infections, such as tuberculosis and Kaposi's sarcoma, and co-infections, such as HCV, have devastating effects on ..
  19. ANTIVIRAL ACTIVITY OF THE IMMUNOSUPPRESSANT LEFLUNOMIDE
    W James Waldman; Fiscal Year: 2004
    ..pharmacologic immunosuppression puts transplant recipients at risk for development of opportunistic infections. Of these, cytomegalovirus (CMV) remains one of the most common sources of serious complications, ..
  20. Genome Integrity in Candida albicans
    Judith G Berman; Fiscal Year: 2007
    DESCRIPTION (provided by applicant): Opportunistic infections remain the most important complication of infection with the Human Immunodeficiency Virus (HIV) and the principal cause of death in patients with the Acquired Immune Deficiency ..
  21. Antifungal Drug Susceptibility of Cryptococcus neoformans
    Robert A Larsen; Fiscal Year: 2008
    ..In the developing world cryptococcal meningitis and pulmonary tuberculosis are the two most common opportunistic infections. Presently selection of which anti-fungal agent (amphotericin B, fluconazole or the two combined), the ..
  22. Ribozymes for studies and treatment of cytomegalovirus infections
    Fenyong Liu; Fiscal Year: 2008
    DESCRIPTION (provided by applicant): Human cytomegalovirus (HCMV) causes one of the most common opportunistic infections in patients with AIDS...
  23. Antifungal Drug Susceptibility of Cryptococcus neoformans
    Robert A Larsen; Fiscal Year: 2007
    ..In the developing world cryptococcal meningitis and pulmonary tuberculosis are the two most common opportunistic infections. Presently selection of which anti-fungal agent (amphotericin B, fluconazole or the two combined), the ..
  24. Improving Platelet Recovery After Radiation
    George E Georges; Fiscal Year: 2008
    ..Severe neutropenia results in sepsis and death due to opportunistic infections and thrombocytopenia results in increased risk of hemorrhage and death due to bleeding...
  25. Immune Recovery Following LLME Treated Cell Therapy
    Joanne Filicko; Fiscal Year: 2006
    ..Unfortunately, outcome is limited by development of graft-versus-host disease (GVHD) and by the opportunistic infections (OI) which often ensue as a consequence of efforts to prevent or treat GVHD...
  26. Human Beta-Defensin-1 in HSV-1 Innate Immunity
    LISA KATHLEEN RYAN; Fiscal Year: 2007
    ..PDC in the circulation, along with depletion of CD4 T-lymphocytes is associated with the development of opportunistic infections, including viral infections...
  27. Nicotine & Immunopathogenesis of Cryptococcal meningitis
    Mohan L Sopori; Fiscal Year: 2007
    DESCRIPTION (provided by applicant): Opportunistic infections of the central nervous system are common complication in acquired immunodeficiency syndrome (AIDS) patients...
  28. New Drugs for Opportunistic Infections
    Alice M Clark; Fiscal Year: 2008
    ..Public Health Relevance: This Public Health Relevance is not available...
  29. New Drugs for Opportunistic Infections
    Alice M Clark; Fiscal Year: 2007
    ..This information will expand the foundation of knowledge regarding the therapeutic control of these infections and the understanding of the basic biology of these pathogens...
  30. Increasing Animal Foods in Diets of HIV-Infected Kenyan Women and Their Children
    Judith A Ernst; Fiscal Year: 2008
    ..of iron and zinc, results in improved clinical outcomes, B weight gain, lean body mass, resistance to opportunistic infections, growth and development in children and ability to carry out normal tasks of daily living in women...
  31. DRUG DESIGN FOR TREATING OPPORTUNISTIC INFECTION IN AIDS
    Kurt L Krause; Fiscal Year: 2003
    Mortality in AIDS patients is due to overwhelming opportunistic infections caused by bacteria, fungi, protozoa, and viruses...
  32. Innate immune response modulators
    Daniela Verthelyi; Fiscal Year: 2003
    ..in the area of Bioterrorism, but also in reducing the susceptibility of immunosuppressed subjects to opportunistic infections. Particular areas of interest include: a) Establishing the safety and effectiveness of CpG ODN as ..
  33. Characterization of Primate Retroviruses
    RAOUL BENVENISTE; Fiscal Year: 2002
    ..disease in macaques that is manifested by progressive weight loss, persistent diarrhea, anemia, opportunistic infections, and unusual neoplasms...
  34. STRUCTURE BASED DRUG DESIGN
    Robert M Stroud; Fiscal Year: 2004
    ..These are each the source of major opportunistic infections that cause early death, especially in patients with AIDS...
  35. Antigenic variation by multiple promoter inversions in Mycoplasma penetrans
    Michael J Calcutt; Fiscal Year: 2008
    DESCRIPTION (provided by applicant): Human mycoplasmas cause chronic and opportunistic infections and may also contribute to the pathogenesis of other microbial agents. Indeed, epidemiological studies reveal that M...
  36. 7th International Congress on Toxoplasmosis
    Kami Kim; Fiscal Year: 2003
    ..Toxoplasma gondii is a major cause of opportunistic infections in AIDS patients as well as birth defects in infants exposed in utero...
  37. Lipophilic antifolates and AIDS opportunistic infections
    Andre Rosowsky; Fiscal Year: 2004
    ..Analogs of PT653 with a COOH, NH2, or OH group on the tricyclic moiety, and prodrugs thereof, will be made with the goal of improving aqueous solubility without sacrificing potency or selectivity...
  38. CYTOKINE RESPONSE IN FIV AND SIV IMMUNODEFICIENCY
    Gregg A Dean; Fiscal Year: 2002
    ..a number of original and significant studies on the identification of lentivirus target cells, effects of opportunistic infections on immunodeficiency virus pathogenesis, and the role of cytokines in immunodeficiency virus pathogenesis...
  39. Randomized, controlled trial of daily trimethoprim-sulfamethoxazole or weekly chl
    Christopher V Plowe; Fiscal Year: 2008
    ..TS) reduces disease and death among people living with HIV in sub-Saharan Africa by preventing opportunistic infections including bacteremia, pneumonia and enteritis as well as malaria...
  40. Development of immune assays for HPV-32
    MICHAEL EDWARD HAGENSEE; Fiscal Year: 2006
    DESCRIPTION (provided by applicant): Opportunistic infections of the oral cavity afflict 50% of all HIV infected patients, and include oropharyngeal candidiasis (OPC), oral hairy leukoplakia (OHL) and oral warts caused by the mucosatropic ..
  41. Non-Viral Delivery of DNA Vaccines to the Buccal Mucosa
    Maria S Salvato; Fiscal Year: 2003
    ..These studies will lead to improved oral vaccines against AIDS and its attendant opportunistic infections. Once we have optimized the vaccine formulation in the murine model system, we will apply the targeted ..
  42. Cryptococcus gatti mating 1oci; mapping and gene study
    VISHNU P CHATURVEDI; Fiscal Year: 2004
    ..neoformans infections have been mostly recognized in Europe. Both primary and opportunistic infections due to var...
  43. Molecular Analysis of a Highly Pathogenic FIV
    John H Elder; Fiscal Year: 2008
    ..a rapid and precipitous decline in CD4+ T cells, thymus atrophy, severe neutropenia, and death due to opportunistic infections in approximately 60% of infected animals within the five months of infection...
  44. Molecular Analysis of a Highly Pathogenic FIV
    John H Elder; Fiscal Year: 2007
    ..a rapid and precipitous decline in CD4+ T cells, thymus atrophy, severe neutropenia, and death due to opportunistic infections in approximately 60% of infected animals within the five months of infection...
  45. Pharmacogenetics of sulfamethoxazole in HIV/AIDS patients
    Danxin Wang; Fiscal Year: 2008
    ..Cotrimoxazole (Trimethoprim-sulfamethoxazole, TMP-SMX) is the agent of choice for prophylaxis against opportunistic infections associated with HIV/AIDS and other immuno-compromised states...
  46. LLME TREATED T LYMPHOCYTE THERAPY AFTER ALLOGENEIC BMT
    Neal Flomenberg; Fiscal Year: 2002
    ..Unfortunately, outcome is limited by development of graft-versus-host disease (GVHD) and by the opportunistic infections which often ensue as a consequence of efforts to prevent or treat GVHD...
  47. APEs as novel drug targets in AIDS opportunistic pathogen Toxoplasma
    WILLIAM J SULLIVAN JR.; Fiscal Year: 2008
    ..The latter two are on the NIAID list of pathogens of interest for Biodefense, but are also serious opportunistic infections in AIDS...
  48. Impact of selenium/zinc levels on HIV disease and treatment response in children
    Torsak Bunupuradah; Fiscal Year: 2008
    ..The standard of care for HIV-infected children includes antiretroviral treatment (ART), prophylaxis for opportunistic infections, and also nutritional support...
  49. Enhancement of Post-BMT Immune Reconstitution by IL-7
    Kenneth I Weinberg; Fiscal Year: 2006
    ..regenerate a full repertoire and normal numbers of T lymphocytes results in morbidity and mortality from opportunistic infections or viral-associated malignancies...
  50. Oral infection and inflammation in transplant patients
    ANNA I DONGARI-BAGTZOGLOU; Fiscal Year: 2005
    ..population; b) collect preliminary data on a possible association between the presence of these oral opportunistic infections and a history of chronic rejection; and c) determine the levels of IL-6 and CRP in the serum of ..
  51. HIV Pathogenesis: Differential Effects on Lymphocyte Sub
    Dennis D Taub; Fiscal Year: 2006
    ..With the advent of life-prolonging therapies such as anti-retroviral drugs for opportunistic infections, an increase in life expectancy post HIV exposure has been observed worldwide with approximately 580 ..
  52. A lateral flow CD4 counting assay for resource-poor regions
    Michael J Lane; Fiscal Year: 2007
    ..surveillance; to monitor the rate of progression to AIDS, to define when therapy is required to prevent opportunistic infections, to place drug-naive patients into cohorts prior to therapy, and to monitor the effects of anti-..
  53. Beckman Coulter BioMek 2000 Workstation and Accessories
    Joseph M McCune; Fiscal Year: 2002
    ..being developed for the assessment of specific human CD4+ and CD8+ T cell responses to other AIDS-related opportunistic infections, including those caused by Mvcobacterium tuberculosis, the Mvcobacterium avium complex, Pneumocvstis ..
  54. Receptor Affects Fungal Mucosal Colonization in HIV
    Mary Ann Jabra-Rizk; Fiscal Year: 2005
    DESCRIPTION (provided by applicant): The oral cavity is a primary target for opportunistic infections in HIV+ patients...
  55. Movement of Recipient T-Cells Away From an Allograft
    Mark C Poznansky; Fiscal Year: 2003
    ..immunosuppressive therapies is achieved at the cost of an increased incidence of life threatening opportunistic infections and transplantation associated malignancies...
  56. ADDICTION THERAPY: METABOLISM AND TRANSPORT-MEDIATED DRUG INTERACTIONS
    Evan D Kharasch; Fiscal Year: 2008
    ..research is to improve treatment of the intertwined diseases of opiate addiction, HIV/AIDS and coexisting opportunistic infections. Methadone and buprenorphine are the cornerstone therapies for opiate addiction, however their ..
  57. Modulating the tumor micro-environment in CLL using flavopiridol and lenalidomide
    Kristie A Blum; Fiscal Year: 2008
    ..is limited in patients with bulky adenopathy and is associated with profound immunosuppression and opportunistic infections. Therefore, novel non-immunosuppressive therapeutic agents with activity in genetically high risk CLL are ..
  58. APEs as novel drug targets in AIDS opportunistic pathogen Toxoplasma
    WILLIAM J SULLIVAN JR.; Fiscal Year: 2007
    ..The latter two are on the NIAID list of pathogens of interest for Biodefense, but are also serious opportunistic infections in AIDS...
  59. Structure Biology and Targeted Drug Design for AIDS
    Paul R Ortiz de Montellano; Fiscal Year: 2006
    ..key proteins of the human immunodeficiency virus (HIV) and of two organisms responsible for HIV-related opportunistic infections is proposed...
  60. Modulating the tumor micro-environment in CLL using flavopiridol and lenalidomide
    KRISTIE A kristieblum@osumcedu BLUM; Fiscal Year: 2009
    ..is limited in patients with bulky adenopathy and is associated with profound immunosuppression and opportunistic infections. Therefore, novel non-immunosuppressive therapeutic agents with activity in genetically high risk CLL are ..
  61. Toll-Like Receptors in Bacterial Antigen Induced HIV-LTR
    OZLEM K EQUILS; Fiscal Year: 2004
    In HIV infected patients, plasma HIV load increases with concomitant opportunistic infections, including Mycobacterial and Chlamydial infections suggesting cell activation and active virus replication...
  62. Molecular Mechanism of Severe Congenital Neutropenia
    H Leighton Grimes; Fiscal Year: 2008
    DESCRIPTION (provided by applicant): Severe Congenital Neutropenia (SCN) predisposes affected humans to opportunistic infections because of a profound deficiency in the production of neutrophils...

Publications62

  1. Fluconazole versus itraconazole for antifungal prophylaxis in neutropenic patients with haematological malignancies: a meta-analysis of randomised-controlled trials
    Konstantinos Z Vardakas
    Alfa Institute of Biomedical Sciences (AIBS, Athens, Greece
    Br J Haematol 131:22-8
    ....
  2. Fatal necrotizing stomatitis due to Trichoderma longibrachiatum in a neutropenic patient with malignant lymphoma: a case report
    Y Myoken
    Department of Oral Surgery, Hiroshima Red Cross and Atomic Bomb Survivors Hospital, Hiroshima, Japan
    Int J Oral Maxillofac Surg 31:688-91
    ..While Trichoderma species have been recognized to be pathogenic in profoundly immunosuppressed hosts, this is the first report of the primary oral focus causing a fatal infection...
  3. [Infections in immunosuppressed children]
    Karianne Wiger
    Barnemedisinsk avdeling, Ullevål universitetssykehus, 0407 Oslo
    Tidsskr Nor Laegeforen 125:1168-72
    ..Patients already treated with cefotaxime should be switched to meropenem, possibly in combination with vancomycin. Antifungal and/or anti-anaerobic treatment should also be considered...
  4. A novel type of metastatically spreading subcutaneous aspergillosis without epidermal lesions following allogeneic stem cell transplantation
    O A Cornely
    Department I of Internal Medicine, Hematology, Oncology and Infectious Diseases, University of Cologne, Cologne, Germany
    Bone Marrow Transplant 28:899-901
    Systemic mycosis is among the most feared opportunistic infections in the immunocompromised host. Difficulty and delay in diagnosis and treatment often result in poor outcomes...
  5. Fungal infections in nontransplant patients with hematologic malignancies
    Brahm H Segal
    Division of Infectious Diseases, SUNY at Buffalo, Roswell Park Cancer Institute, Elm and Carlton Streets, Buffalo, NY 14263, USA
    Infect Dis Clin North Am 16:935-64, vii
    ..This article reviews the epidemiology, clinical manifestations, diagnostic evaluation, and treatment of the major fungal pathogens in nontransplant patients with hematologic malignancies...
  6. Changing patterns and trends in systemic fungal infections
    Malcolm D Richardson
    Department of Bacteriology and Immunology, University of Helsinki, Helsinki, Finland
    J Antimicrob Chemother 56:i5-i11
    ..Fungal opportunistic infections in persons with AIDS are no longer a major problem in developed countries, but are resulting in ..
  7. [Infections in stem cell transplantation]
    Montserrat Rovira
    Unidad de Trasplantament, Servicio Hematología, Hospital Clínic, Barcelona, España
    Enferm Infecc Microbiol Clin 25:477-86
    ..Nevertheless, infection continues to a prominent complication in these patients...
  8. Prolonged survival after invasive aspergillosis: a single-institution review of 11 cases
    Jessica A Wright
    Department of Pediatrics, University of Washington School of Medicine, Seattle, Washington 98105 0371, USA
    J Pediatr Hematol Oncol 25:286-91
    ..The ability to proceed with intensive chemotherapy despite a history of IA may improve long-term survival...
  9. [Successful treatment by voliconazole for pulmonary and adductor magnus muscle aspergillosis induced by immunosuppressive therapy for hypersensitivity pneumonia]
    Hidenori Ichiyasu
    Department of Respiratory Medicine, Faculty of Medical and Pharmaceutical Sciences, Kumamoto University
    Nihon Kokyuki Gakkai Zasshi 44:754-60
    ..Furthermore, the high level of beta-D glucan in serum decreased gradually. This case suggests that administration of VCZ can be recommended for deep seated mycoses...
  10. Disseminated Ochroconis gallopavum infection in a chronic lymphocytic leukemia: a case report and review of the literature on hematological malignancies
    Noriyasu Fukushima
    Department of Internal Medicine, Faculty of Medicine, Saga University, Japan
    Intern Med 44:879-82
    ..Ochroconis gallopavum is a dematiaceous and thermotolerant fungus that causes opportunistic infections in immunocompromised hosts. About only 30 cases of this organism infection have been reported worldwide...
  11. New options for the treatment of invasive fungal infections
    Zachary A Rubin
    Department of Medicine, Emory University Division of Infectious Diseases, Atlanta, GA, USA
    Semin Oncol 31:91-8
    ..We review the clinical data, side effects, drug interactions, and unique spectrum of activity of these newer antifungal agents against both Candida and clinically relevant mold species...
  12. Fungal infection-related mortality versus total mortality as an outcome in trials of antifungal agents
    Anne K Due
    Nordic Cochrane Centre, Rigshospitalet, Dept, 7112, Blegdamsvej 9, DK 2100 København Ø, Denmark
    BMC Med Res Methodol 6:40
    ..Data on total mortality should be reported as well, however, to guard against the possible introduction of harmful treatments...
  13. [Pulmonary mucormycosis: difficulties in diagnosis and treatment]
    A Pipet
    Service de Pneumologie, Centre Hospitalo Universitaire de Nantes, France
    Rev Mal Respir 24:617-21
    ....
  14. [Economic evaluation of the treatment of systemic fungal infections in immunocompromised patients: the role of itraconazole]
    Giorgio L Colombo
    SAVE Studi Analisi Valutazioni Economiche, Milano
    Recenti Prog Med 96:416-23
    ..The lack of studies, national and international, and the small amount of available data on the cost of systemic fungal infections mean that the costs saving from prophylactic and empirical use of antifungals are difficult to estimate...
  15. Fungal infections as a complication of therapy for sarcoidosis
    R P Baughman
    Department of Internal Medicine, University of Cincinnati Medical Center, Cincinnati, OH, USA
    QJM 98:451-6
    ..These agents may render the patient more susceptible to opportunistic infections. In addition, the fungal infection may be difficult to distinguish from the underlying sarcoidosis...
  16. Aspergillus endocarditis in a native valve after amphotericin B treatment
    Anastasia N Kotanidou
    Department of Critical Care and Pulmonary Services, University of Athens, Athens, Greece
    Ann Thorac Surg 78:1453-5
    ..Soon after mitral valve replacement, Aspergillus endocarditis recurred, associated with multiple peripheral emboli, which necessitated a second operation...
  17. [Primary cutaneous aspergillosis in a leukemic child]
    A Torrelo
    Servicios de Dermatología, Hospital del Niño Jesús, Madrid, España
    Actas Dermosifiliogr 98:276-8
    ....
  18. [Clinical study of itraconazole for systemic fungal infections complicated with hematological malignancies--multicenter cooperative study. West-Japan Systemic Fungal Infection Study Group]
    H Shiku
    Osaka Medical Center for Cancer and Cardiovascular Diseases
    Kansenshogaku Zasshi 72:1208-18
    ..6%), and itraconazole may have been associated with them. As a conclusion, itraconazole proved to be effective and safe on SFI developed in patients with various hematological malignancies...
  19. [Complications of hematopoietic stem cell transplantation and the treatment: infections]
    Yoji Ishida
    Nippon Naika Gakkai Zasshi 94:1344-50
  20. Disseminated ochroconis gallopavum infection in a renal transplant recipient: the first reported case and a review of the literature
    T K F Wang
    Centre of Infection, Department of Microbiology, Queen Mary Hospital, University of Hong Kong, Hong Kong, SAR, China
    Clin Nephrol 60:415-23
    Ochroconis gallopavum is a potentially fatal dematiaceous fungus causing opportunistic infections in immunocompromised hosts. We report the first case of disseminated O...
  21. Fatal Scopulariopsis brevicaulis infection in a paediatric stem-cell transplant patient treated with voriconazole and caspofungin and a review of Scopulariopsis infections in immunocompromised patients
    W J Steinbach
    Division of Pediatric Infectious Diseases, Department of Pediatrics, Duke University Medical Center, Box 3499, Durham, NC, USA
    J Infect 48:112-6
  22. [Opportunistic infections in patients with collagen disease]
    Yoshiya Tanaka
    Nippon Naika Gakkai Zasshi 93:1654-9
  23. [Current indications for voriconazole in onco-hematological patients]
    Isidro Jarque
    Servicio de Hematología, Hospital Universitario La Fe, Valencia, Spain
    Rev Iberoam Micol 24:213-6
    ..It should be kept in mind the possibility of breakthrough IFI, particularly zygomycosis, in patients treated with voriconazole for long periods...
  24. Early diagnosis and successful management of atypical invasive Aspergillus sinusitis in a hematopoietic cell transplant patient: a case report
    Yoshinari Myoken
    Department of Oral Surgery, Hiroshima Red Cross and Atomic Bomb Survivors Hospital, Hiroshima, Japan
    J Oral Maxillofac Surg 64:860-3
  25. Sinusitis in the immunocompromised host
    P Rombaux
    Catholic University of Louvain (UCL, Cliniques Universitaires Saint-Luc, Department of Otorhinolaryngology and Head and Neck Surgery, Brussels, Belgium
    Acta Otorhinolaryngol Belg 51:305-13
    ..Early detection of these infections with appropriate anti-infective agents associated with radical or functional endoscopic surgery seems to be the optimal treatment. Recovery of immunity remains the major prognostic factor...
  26. Invasive aspergillosis in patients with hematologic malignancies
    Nathan P Wiederhold
    University of Houston College of Pharmacy, Houston, Texas 77030, USA
    Pharmacotherapy 23:1592-610
    ..The problems and controversies associated with defining optimal treatment strategies for invasive aspergillosis in this heavily immunocompromised population are highlighted...
  27. Fungal pneumonias in transplant recipients
    Remzi Bag
    Baylor College of Medicine, Houston, Texas, USA
    Curr Opin Pulm Med 9:193-8
    ..Value of prophylactic strategies or preemptive therapy remains contentious. New antifungal drugs for managing invasive pulmonary aspergillosis continue to emerge, with better safety, efficacy, and pharmacologic profiles...
  28. [Acute invasive pulmonary aspergillosis in chronic lung disease--a review]
    F Ader
    Service de Réanimation Médicale et Maladies Infectieuses, CH Gustave Dron, Tourcoing, France
    Rev Mal Respir 23:6S11-6S20
    ..CONCLUSION: Acute invasive pulmonary aspergillosis complicating chronic lung disease is not rare. Improved diagnosis procedures and recent therapeutic advances may have a positive impact on patient prognosis...
  29. Simultaneous splenectomy increases risk for opportunistic pneumonia in patients after liver transplantation
    Ulf P Neumann
    Department of Surgery, Virchow Clinic, Humboldt University, Augustenburger Platz 1, 13353 Berlin, Germany
    Transpl Int 15:226-32
    ..Our study identified splenectomy as a major risk factor for the development of opportunistic pneumonia after liver transplantation. In these patients prophylactic protocols and early diagnosis may improve the long-term outcome...
  30. Long-term care after hematopoietic-cell transplantation in adults
    Michael Boeckh
    N Engl J Med 347:1625-6; author reply 1625-6
  31. Predicting outcome after lung resection for invasive pulmonary aspergillosis in patients with neutropenia
    Peter Matt
    Division of Cardio Thoracic Surgery, University Hospital Basel, Spitalstrasse 21, 4031 Basel, Switzerland
    Chest 126:1783-8
    ..Mid- to long-term survival can be achieved if the underlying hematologic disease is under control. It is not yet possible to define a group of patients with IPA who are most likely to benefit from lung resection...
  32. Pseudomembranous tracheobronchial aspergillosis: a rare manifestation of invasive aspergillosis in a non-neutropenic patient with Hodgkin's disease
    D Buchheidt
    III Medizinische Klinik, Universitätsklinikum Mannheim, Ruprecht Karls Universität Heidelberg, Germany
    Mycoses 46:51-5
    ..What is crucial for the clinical management is an early diagnosis by bronchoscopy and cultural proof of the pathogen followed by an adequate antifungal treatment...
  33. First report of Cryptococcus albidus--induced disseminated cryptococcosis in a renal transplant recipient
    Yeon Ah Lee
    Department of Internal Medicine, School of Medicine, Kyung Hee University, Seoul, Korea
    Korean J Intern Med 19:53-7
    ..We report here the first case of disseminated cryptococcosis caused by C. albidus in a renal transplant recipient who had been successfully treated with fluconazole monotherapy...
  34. Lethal subarachnoid bleeding under immunosuppressive therapy due to mycotic arteritis
    Stefanie Weigel
    Department of Clinical Radiology, University Hospital of Muenster, Albert Schweitzer Strasse 33, 48149 Münster, Germany
    Eur Radiol 13:L215-8
    ..Pathologic findings established the rare diagnosis of SAH due to aspergillosis-related mycotic arteritis. Imaging characteristics are presented...
  35. [Infection in compromised hosts--an overview]
    Toru Masaoka
    Osaka Medical Center for Cancer and Cardiovascular Diseases
    Nippon Rinsho 61:122-6
  36. Trichosporonosis in a tertiary care cancer center: risk factors, changing spectrum and determinants of outcome
    Dimitrios P Kontoyiannis
    Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas M D Anderson Cancer Center, Houston, Texas, USA
    Scand J Infect Dis 36:564-9
    ..01). TS is associated with a high mortality rate in cancer patients. The spectrum of infection at our institution has shifted from a predominance of disseminated infection to CVC-related fungemias without evidence of tissue invasion...
  37. [Nosocomial infection due to Trichosporon asahii: clinical revision of 22 cases]
    Gustavo da Silva Rodrigues
    Laboratório SANI, Passo Fundo, Brasil
    Rev Iberoam Micol 23:85-9
    ..So, in susceptible patients to develop trichosporonosis it is advisable to take into consideration this disease especially in intensive clinical care units...
  38. Treatment of non-Aspergillus moulds in immunocompromised patients, with amphotericin B lipid complex
    John R Perfect
    Department of Medicine and Microbiology, Duke University Medical Center, Durham, North Carolina 27710, USA
    Clin Infect Dis 40:S401-8
    ..In an area with little guidance for therapy, the CLEAR data indicate that ABLC can be an effective broad-spectrum treatment choice for several invasive and refractory non-Aspergillus mould infections...
  39. Why prior fluconazole use is associated with an increased risk of invasive mold infections in immunosuppressed hosts: an alternative hypothesis
    Dimitrios P Kontoyiannis
    Clin Infect Dis 34:1281-3; author reply 1283
  40. [New advances in antifungal agents]
    Satoru Matsumoto
    Nippon Yakurigaku Zasshi 130:45-51
  41. Changing epidemiology of systemic fungal infections
    M Richardson
    Department of Bacteriology and Immunology, University of Helsinki, and Helsinki University Central Hospital Laboratory Diagnostics, Helsinki, Finland
    Clin Microbiol Infect 14:5-24
    ....
  42. [The 50th Anniversary Educational Symposium of the Japanese Society for Medical Mycology: Visceral mycoses]
    Shigefumi Maesaki
    Nippon Ishinkin Gakkai Zasshi 48:183
  43. Scopulariopsis brevicaulis infection in a patient with acute myeloid leukemia
    K P Ng
    Department of Medical Microbiology, Faculty of Medicine, University of Malaya, 50603 Kuala Lumpur
    Med J Malaysia 58:608-12
    ..Scopulariopsis brevicaulis was the only pathogen isolated from blood cultures. The fever subsided with itraconazole and there was no recurrence of fungal infection with prolonged maintenance of oral itraconazole...
  44. Acute lung infections in normal and immunocompromised hosts
    Stephen Waite
    Department of Diagnostic Radiology, University of Maryland School of Medicine, Baltimore, MD 21201, USA
    Radiol Clin North Am 44:295-315, ix
    ..Because there often is considerable overlap, infections are categorized by the host immune status that is most likely to be associated with a particular pathogen...
  45. [Radiology of invasive fungal infections of the respiratory tract]
    Alberto Hidalgo
    Sección de Radiología Torácica, Servicio de Radiodiagnóstico, Hospital de la Santa Creu i Sant Pau, S Antoni M Claret 167, Barcelona, Spain
    Rev Iberoam Micol 24:14-8
    ..The following is a review of the imaging features of different invasive fungal infections we can face in our daily practice...
  46. Continuous infusion of escalated doses of amphotericin B deoxycholate: an open-label observational study
    Alexander Imhof
    Department of Internal Medicine, Medical Clinic B, University Hospital, Zürich, Switzerland
    Clin Infect Dis 36:943-51
    ..In conclusion, continuous infusion of AmB-d escalated to 2.0 mg/kg/day seems not to cause additional impairment of vital organ functions and to be well tolerated by most patients...
  47. Immunotherapy for fungal infections
    Brahm H Segal
    Department of Medicine, Roswell Park Cancer Institute, Buffalo, NY 14263, USA
    Clin Infect Dis 42:507-15
    ..g., vaccines). Immunotherapy must be tailored to specific immunocompromised states. Challenges exist in bringing promising immunotherapies from the laboratory to clinical trials...
  48. Immunoparalysis as a cause for invasive aspergillosis?
    Koen J Hartemink
    Department of Intensive Care, VU University Medical Center, PO Box 7057, 1007 MB, Amsterdam, The Netherlands
    Intensive Care Med 29:2068-71
    Aspergillus infections are among the most feared opportunistic infections in humans. These organisms are ubiquitous in nature; protection against infection is usually provided by anatomical barriers and by the immune system...
  49. Pseudomembranous necrotizing tracheobronchitis caused by Aspergillus spp--contribution of one case with acute myeloid leukemia
    Maria I Spasova
    Department of Pediatrics and Medical Genetics, Medical University, Plovdiv, Bulgaria
    Folia Med (Plovdiv) 48:93-7
    ..The diagnostic methods, therapeutic possibilities and differential diagnosis of this rare infectious complication in immunocompromised patients are discussed...
  50. [Paecilomyces lilacinus systemic infection in an immunocompromised child]
    Jorge Roque
    Unidad Cuidados Intensivos de Pediatría, Hospital San Juan de Dios, Santiago de Chile
    Rev Med Chil 131:77-80
    ..Blood and bone marrow cultures were positive. The patient was treated with amphotericin B and itraconazole with a good clinical response...
  51. Non-sporulating Chrysosporium: an opportunistic fungal infection in a neutropenic patient
    G G Gan
    Department of Medicine, Faculty of Medicine, University of Malaya, 50603, Kuala Lumpur
    Med J Malaysia 57:118-22
    ..This patient presented with a persistent lobar pneumonia, skin lesions, and possible involvement of the central nervous system. The patient responded to treatment with amphotericin B and oral itraconazole...
  52. Autopsy case of disseminated Trichosporon inkin infection identified with molecular biological and biochemical methods
    Takahiro Koyanagi
    Department of Pathology, St Mary's Hospital, Kurume, Japan
    Pathol Int 56:738-43
    ..It is difficult to make a diagnosis of Trichosporon infection on only histological examination; therefore, molecular biological and biochemical methods are needed in a diagnosis of disseminated trichosporonosis...
  53. Improved outcome of zygomycosis in patients with hematological diseases?
    B Gleissner
    Department of Hematology, Oncology and Transfusion Medicine, University Hospital Benjamin Franklin, Free University of Berlin, Germany
    Leuk Lymphoma 45:1351-60
    ..Alternative treatment options lead only in a few patients to success...
  54. Opportunistic infections in renal allograft recipients
    R K Gupta
    Department of Pathology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India
    Transplant Proc 39:731-3
    ..The overall incidence of opportunistic infections varies from center to center; up to 15% of renal transplant recipients die of these infections...
  55. Amphotericin B lipid complex in the management of invasive aspergillosis in immunocompromised patients
    Pranatharthi H Chandrasekar
    Division of Infectious Diseases, Wayne State University School of Medicine, Harper University Hospital, Detroit, Michigan 48201, USA
    Clin Infect Dis 40:S392-400
    ..Analysis of this large database demonstrated the efficacy and safety of ABLC in the treatment of invasive aspergillosis...
  56. A case of primary cutaneous aspergillosis in a renal transplant recipient
    S B Park
    Department of Internal Medicine, Keimyung University School of Medicine, Daegu, Korea
    Transplant Proc 36:2156-7
    ..Therefore, most lesions were excised surgically and liposomal amphotericin B continued for 2 weeks followed by treatment with oral fluconazole for 2 months. Ten moths later there was no evidence of recurrence...
  57. Fungal infections in marrow transplant recipients under antifungal prophylaxis with fluconazole
    J S R Oliveira
    Disciplina de Hematologia e Hemoterapia, Escola Paulista de Medicina, Universidade Federal de São Paulo, São Paulo, SP, Brasil
    Braz J Med Biol Res 35:789-98
    ..At that time, blood and spinal fluid cultures yielded Fusarium sp. Opportunistic infections due to fungi other than Candida spp are becoming a major problem among BMT patients receiving systemic ..